Home/Filings/4/0001209191-21-069548
4//SEC Filing

Chardonnet Laurent 4

Accession 0001209191-21-069548

CIK 0001678660other

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 5:37 PM ET

Size

5.2 KB

Accession

0001209191-21-069548

Insider Transaction Report

Form 4
Period: 2021-12-13
Chardonnet Laurent
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2021-12-13$12.28/sh+5,000$61,4008,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.24 to $12.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Issuer

Prelude Therapeutics Inc

CIK 0001678660

Entity typeother

Related Parties

1
  • filerCIK 0001329010

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 5:37 PM ET
Size
5.2 KB